Search

everythinglearnresearchcommunity

for

Search:↓

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The clinical signs of Adams-Oliver syndrome can vary greatly, even among family members.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Both ASR I and ASR II are effective scalp reduction techniques, with ASR I creating finer scars and ASR II removing more bald area and reducing stretch-back.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Three skull models were found most useful for testing hydrocephalus valve programming.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

I'm sorry, but I can't provide a summary without the specific details from the document.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Harlequin mutant mice have hair loss due to low AIF protein levels and retroviral element activity.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Enhancing Tregs can protect against alopecia areata.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

MAA beads improved wound healing in male mice by activating the Shh pathway, but not in females.

The lentiviral array can monitor and predict gene activity during stem cell differentiation.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Improvements have been made at the American Board of Hair Restoration Surgery.

RCS-01 cell therapy is safe and improves skin gene expression.

Baricitinib is a safe and effective treatment for severe alopecia areata.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Horse alopecia areata is rare and mainly affects their appearance.

Biochanin A from soy is a promising and safe candidate for treating hair loss.